T2 Biosystems sells four T2Dx Instruments to European distributor
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2024
0mins
Source: SeekingAlpha
T2 Biosystems Expansion: T2 Biosystems is selling four T2Dx Instruments to its European distributor, enhancing the availability of their diagnostic tests for sepsis patients.
Financial Growth: The company reported a 35% increase in revenue for Q3 2024, indicating strong commercial performance and growth.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
